Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 29;14(2):e079305.
doi: 10.1136/bmjopen-2023-079305.

Digital computerised cognitive training for preventing cognitive decline among hypertensive patients: a study protocol for a multicentre randomised controlled trial (DELIGHT trial)

Affiliations

Digital computerised cognitive training for preventing cognitive decline among hypertensive patients: a study protocol for a multicentre randomised controlled trial (DELIGHT trial)

Yu Kong et al. BMJ Open. .

Abstract

Introduction: Mild cognitive impairment (MCI) is an important intervenable stage for the prevention of dementia. Hypertension is associated with impaired cognition, and when combined with MCI, it may lead to a poor prognosis. Digital computerised cognitive training (CCT) has recently become a potential instrument for improving cognition, but evidence for its efficacy remains limited. This study aims to evaluate the efficacy of a digital adaptive CCT intervention in older patients with hypertension and MCI.

Methods and analysis: The multicentre, double-blinded, randomised, actively -controlled clinical trial will recruit 200 older (≥60 years) patients with hypertension and MCI from 11 hospitals across China. Participants will be randomly assigned in a 1:1 ratio to the intervention group (multidomain adaptative CCT) and active control group (non-adaptive cognitive training) for 12-week cognitive training for 30 min/day and 5 days/week. Those who have completed their 12-week training in the intervention group will be rerandomised into the continuation and discontinuation training groups. All participants will be followed up to 24 weeks. Neuropsychological assessments and structural and functional 7.0 T MRI will be obtained at baseline and at 12-week and 24-week follow-up. The primary outcome is the possible improvement of global cognitive function at 12 weeks, as measured by the Basic Cognitive Aptitude Tests. Secondary and exploratory endpoints include the major cognitive domain function improvement, self-efficacy, mental health, quality of life and MRI measurements of the brain.

Ethics and dissemination: The trial has been approved by the institutional review board of Beijing Anzhen Hospital and thereafter by all other participating centres. Trial findings will be disseminated in peer-reviewed journals and conference presentations.

Trial registration number: NCT05704270.

Keywords: CARDIOLOGY; Delirium & cognitive disorders; Hypertension; Nephrology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart. MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment Scale.

Similar articles

References

    1. Lobanov-Rostovsky S, He Q, Chen Y, et al. . Growing old in China in socioeconomic and Epidemiological context: systematic review of social care policy for older people. BMC Public Health 2023;23. 10.1186/s12889-023-15583-1 - DOI - PMC - PubMed
    1. Liu Y, Ma W, Li M, et al. . Relationship between physical performance and mild cognitive impairment in Chinese community-dwelling older adults. Clin Interv Aging 2021;16:119–27. 10.2147/CIA.S288164 - DOI - PMC - PubMed
    1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223–37. 10.1038/s41581-019-0244-2 - DOI - PMC - PubMed
    1. Ungvari Z, Toth P, Tarantini S, et al. . Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol 2021;17:639–54. 10.1038/s41581-021-00430-6 - DOI - PMC - PubMed
    1. Peters R, Schuchman M, Peters J, et al. . Relationship between antihypertensive medications and cognitive impairment: part II. Curr Hypertens Rep 2016;18. 10.1007/s11906-016-0673-2 - DOI - PMC - PubMed

Publication types

Associated data